B. D. Agnis, D. S. Berman, D. Spicehandler, W. El-sadr, M. S. Simberkoff et al., Effect of Combined Therapy with Ansamycin, Clofazimine, Ethambutol, and Isoniazid for Mycobacterium avium Infection in Patients with AIDS, Journal of Infectious Diseases, vol.159, issue.4, pp.784-787, 1989.
DOI : 10.1093/infdis/159.4.784

E. J. Baron and L. S. Young, Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome, Diagnostic Microbiology and Infectious Disease, vol.5, issue.3, pp.215-220, 1986.
DOI : 10.1016/0732-8893(86)90004-0

J. Chiu, J. Nussbaum, S. Bozette, J. G. Tilles, L. S. Young et al., Treatment of Disseminated Mycobacterium avium Complex Infection in AIDS with Amikacin, Ethambutol, Rifampin, and Ciprofloxacin, Annals of Internal Medicine, vol.113, issue.5, pp.358-361
DOI : 10.7326/0003-4819-113-5-358

A. J. Crowle, R. Dahl, E. Ross, and M. H. , Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic, Infect. Immun, vol.59, pp.1823-1831, 1991.

P. Dellamonica, Primary prevention of opportunistic infections in AIDS patients, abstr. 5. In Roxithromycin, the first of the new generation of macrolides: experience and prospective. Satellite symposium 1503, 1993.

E. T. Etzkorn, S. Aldarondo, C. K. Mcalister, J. Matthews, and A. J. Ognibene, Medical therapy of Mycobacterium aviumintracellulare pulmonary disease, Am. Rev. Respir. Dis, vol.134, pp.442-445, 1986.

. Dwyer, Quadruple-drug therapy for Mycobacterium aviumintracellulare bacteremia in AIDS patients, J. Infect. Dis, vol.161, pp.801-805, 1990.

C. B. Inderlied, F. G. Sandoval, and L. S. Young, In vitro activity of clarithromycin (CLARI) and 14-hydroxy-clarithromycin against the Mycobacterium avium complex (MAC) alone and in combination with other agents, abstr. 239. Abstr. 31st Intersci, Conf. Antimicrob. Agents Chemother, 1991.

B. Ji, N. Lounis, C. Truffot-pernot, and J. H. Grosset, In vitro activities of clarithromycin-containing double-or triple-drug combinations against Mycobacterium avium complex, p.155, 1992.

N. Rastogi, Mycobacteria and AIDS: epidemiological and genetic markers, virulence factors and interactions with the immune system, Research in Microbiology, vol.143, issue.4, pp.361-436
DOI : 10.1016/0923-2508(92)90046-Q

N. Rastogi, Mycobacteria as intracellular pathogens: current notions of pathogenicity, virulence, and drug resistance and their relation to effective therapy Antimicrobial agents and intracellular pathogens, pp.245-300, 1993.

N. Rastogi, C. Frehel, A. Ryter, H. Ohayon, M. Lesourd et al., Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?, Antimicrobial Agents and Chemotherapy, vol.20, issue.5, pp.666-677, 1981.
DOI : 10.1128/AAC.20.5.666

N. Rastogi and K. S. Goh, Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria., Antimicrobial Agents and Chemotherapy, vol.36, issue.12, pp.2841-2842, 1992.
DOI : 10.1128/AAC.36.12.2841

N. Rastogi, K. S. Goh, and A. Bryskier, In vitro activity of roxithromycin against 16 species of atypical mycobacteria and effect of pH on its radiometric MICs., Antimicrobial Agents and Chemotherapy, vol.37, issue.7, pp.1560-1562, 1993.
DOI : 10.1128/AAC.37.7.1560
URL : https://hal.archives-ouvertes.fr/pasteur-00925365

N. Rastogi, K. S. Goh, and H. L. David, Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis., Antimicrobial Agents and Chemotherapy, vol.34, issue.5, pp.759-764, 1990.
DOI : 10.1128/AAC.34.5.759

N. Rastogi, K. S. Goh, N. Guillou, and V. Labrousse, Spectrum of drugs against atypical mycobacteria: How valid is the current practice of drug susceptibility testing and the choice of drugs?, Zentralblatt f??r Bakteriologie, vol.277, issue.4, pp.474-484, 1992.
DOI : 10.1016/S0934-8840(11)80472-X

N. Rastogi and V. Labrousse, Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex., Antimicrobial Agents and Chemotherapy, vol.35, issue.3, pp.462-470, 1991.
DOI : 10.1128/AAC.35.3.462

N. Rastogi, V. Labrousse, J. P. Carvalho, and . Sousa, Ethambutol potentiates extracellular and intracellular activities of clarithromycin, sparfloxacin, amikacin, and rifampin againstMycobacterium avium, Current Microbiology, vol.8, issue.4, pp.191-196, 1993.
DOI : 10.1007/BF01577376

N. Rastogi, V. Labrousse, K. S. Goh, J. P. Carvalho, and . Sousa, Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages., Antimicrobial Agents and Chemotherapy, vol.35, issue.12, pp.2473-2480, 1991.
DOI : 10.1128/AAC.35.12.2473

N. Rastogi, B. C. Ross, B. Dwyer, K. S. Goh, S. Clavel-seres et al., Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain ofMycobacterium tuberculosis, European Journal of Clinical Microbiology & Infectious Diseases, vol.29, issue.Supplement 1, pp.901-907, 1992.
DOI : 10.1007/BF01962370

F. Staufer, E. Dortbudak, and . Lahonilk, Wirksamkeit von Clarithromycin in Kombination mit Ethambutol und Rifampicin gegen Mycobacterium avium-Komplex basierend auf Invitro-Untersuchungen, Infection, vol.68, issue.5, pp.343-345, 1991.
DOI : 10.1007/BF01645362

P. M. Tulkens, Intracellular distribution and activity of antibiotics, European Journal of Clinical Microbiology & Infectious Diseases, vol.29, issue.Supplement D, pp.100-106, 1991.
DOI : 10.1007/BF01964420

D. M. Yajko, In vitro activity of antimicrobial agents against the Mycobactenium avium complex inside macrophages from, 1992.